Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study

Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are a class of antidiabetic agents known to exert cardioprotective, renoprotective, and hypoglycemic effects. However, these agents have been associated with adverse effects, such as genital infection, volume depletion, hypoglycemia, and diabetic k...

Descripción completa

Detalles Bibliográficos
Autores principales: Saijo, Yuto, Okada, Hiroshi, Hata, Shinnosuke, Nakajima, Hanako, Kitagawa, Nobuko, Okamura, Takuro, Osaka, Takafumi, Kitagawa, Noriyuki, Majima, Saori, Senmaru, Takafumi, Ushigome, Emi, Nakanishi, Naoko, Hamaguchi, Masahide, Fukui, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672375/
https://www.ncbi.nlm.nih.gov/pubmed/38002608
http://dx.doi.org/10.3390/jcm12226993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672375/
https://www.ncbi.nlm.nih.gov/pubmed/38002608
http://dx.doi.org/10.3390/jcm12226993

Ejemplares similares